The diagnosis of rupture of fetal membranes (ROM): A meta-analysis

Journal of Perinatal Medicine

Volumn 41, Issue 3, 2013, Pages 233-240

  Ramsauer, Babett ^a   Vidaeff, Alex C ^b   Hosli, Irene ^c   Park, Joong Shin ^d   Strauss, Alexander ^e   Khodjaeva, Zulfiya ^f   De La Cruz, Angel Aguaron ^g   Martinez Astorquiza, Txanton ^h   Horovitz, Jacques ⁱ   Coatleven, Frederic ⁱ   Helmer, Hanns ^j  

^a VIVANTES KLINIKUM NEUKÖLLN   (Germany)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY HOSPITAL BASEL   (Switzerland)

^d Seoul National University   (South Korea)

^e UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^f RESEARCH CENTER OF OBSTETRICS   (Russian Federation)

^g UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^h HOSPITAL DE CRUCES   (Spain)

ⁱ UNIVERSITÉ DE BORDEAUX   (France)

^j MEDICAL UNIVERSITY OF VIENNA   (Austria)

more..

Author keywords

Clinical relevance; Insulin like growth factor binding protein (IGFBP 1); Placental microglobulin 1 (PAMG 1); Premature rupture of fetal membranes (PROM); Uncertain rupture

Indexed keywords

ALPHA 1 MICROGLOBULIN; SOMATOMEDIN BINDING PROTEIN 1;

COHORT ANALYSIS; DIAGNOSTIC ACCURACY; HUMAN; OBSERVATIONAL STUDY; PREMATURE FETUS MEMBRANE RUPTURE; PRIORITY JOURNAL; PROSPECTIVE STUDY; REVIEW;

AMNIOTIC FLUID; BIOLOGICAL MARKERS; CERVIX UTERI; DIAGNOSTIC ERRORS; FEMALE; FETAL MEMBRANES, PREMATURE RUPTURE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 1; PREGNANCY; VAGINA;

EID: 84881564650     PISSN: 03005577     EISSN: 16193997     Source Type: Journal    
DOI: 10.1515/jpm-2012-0247     Document Type: Review

References (50)

1. Akercan F, Cirpan T, Kazandi M, Terek MC, Mgoyi L, Ozkinay E. The value of the insulin-like growth factor binding protein-1 in the cervical-vaginal secretion detected by immunochromatographic dipstick test in the prediction of delivery in women with clinically unconfirmed preterm premature rupture of membranes. Eur J Obstet Gynecol Reprod Biol. 2005;121: 159 - 63.
2. Albayrak M, Ozdemir I, Koc O, Ankarali H, Ozen O. Comparison of the diagnostic efficacy of the two rapid bedside immunoassays and combined clinical conventional diagnosis in prelabour rupture of membranes. Eur J Obstet Gynecol Reprod Biol. 2011;158:179 - 82.
3. Alexander JM, Cox SM. Clinical course of premature rupture of the membranes. Semin Perinatol. 1996;20:369 - 74.
4. Atterbury JL, Groome LJ, Hoff C. Methods used to diagnose premature rupture of membranes: a national survey of 812 obstetric nurses. Obstet Gynecol. 1998;92:384 - 9.
5. Birkenmaier A, Ries JJ, Kuhle J, Burki N, Lapaire O, Hösli I. Placental α-microglobulin-1 to detect uncertain rupture of membranes in a European cohort of pregnancies. Arch Gynecol Obstet. 2012;285:21 - 5.
6. Bogavac M, Simin N, Ranisavljević M, Budisić L. The role of insulin-like growth factor in prediction and prevention of preterm delivery. Vojnosanit Pregl. 2010;67:883 - 6.
7. Chen FC, Dudenhausen JW. Comparison of two rapid strip tests based on IGFBP-1 and PAMG-1 for the detection of amniotic fluid. Am J Perinatol. 2008;25:243 - 6.
8. Cousins LM, Smok DP, Lovett SM, Poeltler DM. AmniSure placental alpha microglobulin-1 rapid immunoassay versus standard diagnostic methods for detection of rupture of membranes. Am J Perinatol. 2005;22:317 - 20.
9. Darj E, Lyrenäs S. Insulin-like growth factor binding protein-1, a quick way to detect amniotic fluid. Acta Obstet Gynecol Scand. 1998;77:295 - 7.
10. de Haan HH, Offermans PM, Smits F, Schouten HJ, Peeters LL. Value of the fern test to confirm or reject the diagnosis of ruptured membranes in modest in nonlaboring women presenting with nonspecific vaginal fluid loss. Am J Perinatol. 1994;11:46 - 50.
11. Devlieger R, Verhaeghe J, Coopmans W, Deprest JA. IGFBP-1 levels in cervicovaginal secretions before and after amniocentesis. Gynecol Obstet Invest. 2009;67:9 - 13.
12. Di Renzo GC, Cabero Roura L, Facchinetti F. The EAPM-Study Group on " Preterm Birth " . Guidelines for the management of spontaneous preterm labor: identification of spontaneous preterm labor, diagnosis of preterm premature rupture of membranes, and preventive tools for preterm birth. J Matern Fetal Neonatal Med. 2011;24:659 - 67.
13. El-Messidi A, Cameron A. Diagnosis of premature rupture of membranes: inspiration from the past and insights for the future. J Obstet Gynaecol Can. 2010;32:561 - 9.
14. Erdemoglu E, Mungan T. Significance of detecting insulin-like growth factor binding protein-1 in cervicovaginal secretions: comparison with nitrazine test and amniotic fluid volume assessment. Acta Obstet Gynecol Scand. 2004;83:622 - 6.
15. Eriksen NL, Parisi VM, Daoust S, Flamm B, Garite TJ, Cox SM. Fetal fibronectin: a method for detecting the presence of amniotic fluid. Obstet Gynecol. 1992;80:451 - 4.
16. Flourié F, Cherfa H, Bornet H. Diagnostic de la rupture des membranes fœ tales par détection de l'insulin growth factor binding protein-1 (IGFBP-1) dans les sécrétions cervicovaginales: interprétation des résultats faiblement positifs. Ann Biol Clin. 2002;60:623 - 4.
17. Gart JJ, Buck AA. Comparison of a screening test and a reference test in epidemiologic studies. II. A probabilistic model for the comparison of diagnostic tests. Am J Epidemiol. 1966;83:593 - 602.
18. Gaucherand P, Salle B, Sergeant P, Guibaud S, Brun J, Bizollon CA, et al. Comparative study of three vaginal markers of the premature rupture of membranes. Insulin like growth factor binding protein 1 diamine-oxidase pH. Acta Obstet Gynecol Scand. 1997;76:536 - 40.
19. Giudice LC. Multifaceted roles for IGFBP-1 in human endometrium during implantation and pregnancy. Ann NY Acad Sci. 1997;828:146 - 56.
20. Goldenberg RL, Culhane JF, Iams JD, Romero R. Epidemiology and causes of preterm birth. Lancet. 2008;71:75 - 84.
21. Guibourdenche J, Luton D, André E, Noël M, Porquet D. Rapid detection of insulin-like growth factor binding protein-1 and foetal fibronectin in cervico-vaginal secretions to diagnose premature membrane rupture. Ann Clin Biochem. 1999;36 (Pt 3):388 - 90.
22. Hellemans P, Verdonk P, Baekelandt M, Joostens M, Francx M, Gerris J. Preliminary results with the use of the ROM-check immunoassay in the early detection of rupture of the amniotic membranes. Eur J Obstet Gynecol Reprod Biol. 1992;43:173 - 9.
23. Jain K, Morris PG. A clinical study to evaluate the usefulness of the MAST test in diagnosing pre labour rupture of membranes. J Obstet Gynaecol. 1998;18:33 - 6.
24. Jeurgens-Borst AJ, Bekkers RL, Sporken JM, van den Berg PP. Use of insulin like growth factor binding protein-1 in the diagnosis of ruptured fetal membranes. Eur J Obstet Gynecol Reprod Biol. 2002;102:11 - 4.
25. Knapik D, Olejek A. Analiza wydzieliny szyjkowo-pochwowej w diagnostyce przedwczesnego pȩkniȩcia błon płodowych. Ginekol Pol. 2011;82:50 - 5.
26. Kubota T, Takeuchi H. Evaluation of insulin-like growth factor binding protein-1 as a diagnostic tool for rupture of the membranes. J Obstet Gynaecol Res. 1998;24:411 - 7.
27. Kurdoglu M, Kolusari A, Adali E, Yildizhan R, Kurdoglu Z, Kucukaydin Z, et al. Does residual amniotic fluid after preterm premature rupture of membranes have an effect on perinatal outcomes ? 12 years experience of a tertiary care center. Arch Gynecol Obstet. 2010;281:601 - 7.
28. Ladfors L, Mattsson LA. Is the use of IGFB-1 for diagnosing ROM of any clinical value. Acta Obstet Gynecol Scand. 1999;78:557 - 8.
29. Lee SM, Lee J, Seong HS, Lee SE, Park JS, Romero R, et al. The clinical significance of a positive Amnisure test in women with term labor with intact membranes. J Matern Fetal Neonatal Med. 2009;22:305 - 10.
30. Lee SE, Park JS, Norwitz ER, Kim KW, Park HS, Jun JK. Measurement of placental alpha-microglobulin 1 in cervicovaginal discharge to diagnose rupture of membranes. Obstet Gynecol. 2007;109:634-40.
31. Lee SM, Yoon BH, Park CW, Kim SM, Park JW. Intra-amniotic inflammation in patients with a positive Amnisure test in preterm labor and intact membranes. Am J Obstet Gynecol. 2011;204(Suppl):S209.
32. Lockwood CJ, Wein R, Chien D, Ghidini A, Alvarez M, Berkowitz RL. Fetal membrane rupture is associated with the presence of insulin-like growth factor-binding protein-1 in vaginal secretions. Am J Obstet Gynecol. 1994;171:146 - 50.
33. Loukovaara M, Koistinen R, Kalme T, Kurki T, Leinonen P, Seppälä M. Serum insulin-like growth factor-I and insulin-like growth factor binding protein-3 in premature rupture of membranes. Acta Obstet Gynecol Scand. 2002;81: 905 - 8.
34. Martinez de Tejada B, Boulvain M, Dumps P, Bischof P, Meisser A, Irion O. Can we improve the diagnosis of rupture of membranes ? The value of insulin-like growth factor binding protein-1. Br J Obstet Gynaecol. 2006;113:1096 - 9.
35. Mercer BM. Premature rupture of the membranes. Obstet Gynecol. 2003;101:178 - 93.
36. Mittal P, Romero R, Soto E, Cordoba M, Chang CL, Vaisbuch E, et al. A role for placental alpha-microglobulin-1 in the identification of women with a sonographic short cervix at risk for spontaneous rupture of membranes. Am J Obstet Gynecol. 2009;201(Suppl):S196- 7.
37. Neil PR, Wallace EM. Is Amnisure ® useful in the management of women with prelabour rupture of the membranes ? Aust NZ J Obstet Gynaecol. 2010;50:534 - 8.
38. Paternoster DM, Pignataro R, Stella A, Bertoldini M, Bracciante R. [Comparative analysis of premature labor markers]. Acta Biomed Ateneo Parmense. 2000;71(Suppl 1):331 - 6. Italian.
39. Pollet-Villard M, Cartier R, Gaucherand P, Doret M. Detection of placental alpha microglobulin-1 versus insulin-like growth factor-binding protein-1 in amniotic fluid at term: a comparative study. Am J Perinatol. 2011;28:489 - 94.
40. Ragosch V, Hundertmark S, Hopp H, Opri F, Weitzel HK. Insulin like growth factor binding protein 1 (IGFBP-1) und fetales Fibronectin in der Diagnostik eines vorzeitigen Blasensprungs. Geburtsh Frauenheilk. 1996;56:291- 6.
41. Rutanen EM, Kärkkäinen TH, Lehtovirta J, Uotila JT, Hinkula MK, Hartikainen AL. Evaluation of a rapid strip test for insulin-like growth factor-binding protein-1 in the diagnosis of ruptured fetal membranes. Clin Chim Acta. 1996;253:91 - 101.
42. Rutanen EM, Pekonen F, Kärkkäinen T. Measurement of insulin-like growth factor binding protein-1 in cervical/vaginal secretions: comparison with the ROM-check Membrane Immunoassay in the diagnosis of ruptured fetal membranes. Clin Chim Acta. 1993;214:73 - 81.
43. Silva E, Martinez JC. Diagnosing ROM: a comparison of the gold standard, indigo carmine amnioinfusion, to the rapid immunoassay, the AmniSure ROM test. J Perinat Med. 2009;37(Suppl 1):956.
44. Tagore S, Kwek K. Comparative analysis of insulin-like growth factor binding protein-1 (IGFBP-1), placental alphamicroglobulin- 1 (PAMG-1) and nitrazine test to diagnose premature rupture of membranes in pregnancy. J Perinat Med. 2010;38:609 - 12.
45. van der Ham DP, van Melick MJ, Smits L, Nijhuis JG, Weiner CP, van Beek JJ, et al. Methods for the diagnosis of rupture of the fetal membranes in equivocal cases: a systematic review. Eur J Obstet Gynecol Reprod Biol. 2011;157:123 - 7.
46. Verhaeghe J, Van Herck E, Billen J, Moerman P, Van Assche FA, Giudice LC. Regulation of insulin-like growth factor-I and insulin-like growth factor binding protein-1 concentrations in preterm fetuses. Am J Obstet Gynecol. 2003;188:485 - 91.
47. Vogel I, Grønbaek H, Thorsen P, Flyvbjerg A. Insulin-like growth factor binding protein 1 (IGFBP-1) in vaginal fluid in pregnancy. In vivo. 2004;18:37 - 41.
48. Watanabe T, Minakami H, Itoi H, Sato I, Sakata Y, Tamada T. Evaluation of latex agglutination test for alpha-fetoprotein in diagnosing rupture of fetal membranes. Gynecol Obstet Invest. 1995;39:15 - 8.
49. Woltmann W, Hofstaetter C, Dudenhausen JW. Nachweis eines Blasensprungs durch die Bestimmung des Insulinlike- growth-factor-Bindungsprotein-1. Z Geburtsh Neonatol. 1995;199:243 - 4.
50. Woytoń J, Kłosek A, Zimmer M, Fuchs T. Insulino podobny białkowy czynnik wzrostu-1 (IGFBP-1) w treści pochwowej jako marker przedwczesnego odpływania wod płodowych (PROM). Ginekol Pol. 2000;70:809 - 14.